Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials

Autor: Hoffmann-Vold, Anna-Maria *, Volkmann, Elizabeth R, Allanore, Yannick, Assassi, Shervin, de Vries-Bouwstra, Jeska K, Smith, Vanessa, Tschoepe, Inga, Loaiza, Lazaro, Kanakapura, Madhu, Distler, Oliver
Zdroj: In The Lancet Rheumatology October 2022 4(10):e679-e687
Databáze: ScienceDirect